Neurotensin regulates cortical glutamate transmission by modulating N‐methyl‐D‐aspartate receptor functional activity: An in vivo microdialysis study

The aim of the present in vivo microdialysis study was to investigate whether the tridecapeptide neurotensin (NT) influences the N‐methyl‐D‐aspartate (NMDA) receptor‐mediated increase of cortical glutamate transmission in freely moving rats. Intracortical perfusion with NT influenced local extracellular glutamate levels in a bell‐shaped, concentration‐dependent manner. One hundred and three hundred nanomolar NT concentrations increased glutamate levels (151% ± 7% and 124% ± 3% of basal values, respectively). Higher (1,000 nM) and lower (10 nM) NT concentrations did not alter extracellular glutamate levels. The NT receptor antagonist SR48692 (100 nM) prevented the NT (100 nM)‐induced increase in glutamate levels. NMDA (100 and 500 μM) perfusion induced a concentration‐dependent increase in extracellular glutamate levels, the lower 10 μM NMDA concentration being ineffective. When NT (10 nM, a concentration by itself ineffective) was added in combination with NMDA (100 μM) to the perfusion medium, a significant greater increase in extracellular glutamate levels (169% ± 7%) was observed with respect to the increase induced by NMDA (100 μM) alone (139% ± 4%). SR48692 (100 nM) counteracted the increase in glutamate levels induced by the treatment with NT (10 nM) plus NMDA (100 μM). The enhancement of cortical glutamate levels induced by NMDA (100 and 500 μM) was partially antagonized by the presence of SR48692, at a concentration (100 nM) that by itself was ineffective in modulating glutamate release. These findings indicate that NT plays a relevant role in the regulation of cortical glutamatergic transmission, especially by modulating the functional activity of cortical NMDA receptors. A possible role in glutamate‐mediated neurotoxicity is suggested. © 2011 Wiley‐Liss, Inc.

[1]  A. Ghanizadeh.  Targeting neurotensin as a potential novel approach for the treatment of autism , 2010, Journal of Neuroinflammation.

[2]  K. Fuxe,et al.  The changing world of G protein-coupled receptors: from monomers to dimers and receptor mosaics with allosteric receptor–receptor interactions , 2010, Journal of receptor and signal transduction research.

[3]  S. Lipton,et al.  Preventing Ca2+-mediated nitrosative stress in neurodegenerative diseases: possible pharmacological strategies. , 2010, Cell calcium.

[4]  E. Richelson,et al.  The novel neurotensin analog NT69L blocks phencyclidine (PCP)-induced increases in locomotor activity and PCP-induced increases in monoamine and amino acids levels in the medial prefrontal cortex , 2010, Brain Research.

[5]  M. Bennett,et al.  Regulation of NMDA receptor Ca2+ signalling and synaptic plasticity. , 2009, Biochemical Society transactions.

[6]  K. Fuxe,et al.  Emerging evidence for neurotensin receptor 1 antagonists as novel pharmaceutics in neurodegenerative disorders. , 2009, Mini reviews in medicinal chemistry.

[7]  A. Rakovska,et al.  Neurotensin modulation of acetylcholine, GABA, and aspartate release from rat prefrontal cortex studied in vivo with microdialysis , 2008, Brain Research Bulletin.

[8]  K. Fuxe,et al.  Neurotensin receptors as modulators of glutamatergic transmission , 2008, Brain Research Reviews.

[9]  A. Caraffa,et al.  Biology of Neurotensin: Revisited Study , 2008, International journal of immunopathology and pharmacology.

[10]  K. Fuxe,et al.  Neurotensin receptor mechanisms and its modulation of glutamate transmission in the brain Relevance for neurodegenerative diseases and their treatment , 2007, Progress in Neurobiology.

[11]  F. Artigas,et al.  Clozapine and Haloperidol Differently Suppress the MK-801-Increased Glutamatergic and Serotonergic Transmission in the Medial Prefrontal Cortex of the Rat , 2007, Neuropsychopharmacology.

[12]  W. Yung,et al.  Neurotensin selectively facilitates glutamatergic transmission in globus pallidus , 2006, Neuroscience.

[13]  T. Koyama,et al.  Role of the simultaneous enhancement of NMDA and dopamine D1 receptor-mediated neurotransmission in the effects of clozapine on phencyclidine-induced acute increases in glutamate levels in the rat medial prefrontal cortex , 2006, Naunyn-Schmiedeberg's Archives of Pharmacology.

[14]  H. Okano,et al.  Bidirectional regulation of dopamine D2 and neurotensin NTS1 receptors in dopamine neurons , 2006, The European journal of neuroscience.

[15]  C. Nemeroff,et al.  Neurotensin: Role in psychiatric and neurological diseases , 2006, Peptides.

[16]  P. Kitabgi.  Functional domains of the subtype 1 neurotensin receptor (NTS1) , 2006, Peptides.

[17]  C. Pothoulakis,et al.  Effects of NT on gastrointestinal motility and secretion, and role in intestinal inflammation , 2006, Peptides.

[18]  J. Vincent,et al.  Internalization and recycling properties of neurotensin receptors , 2006, Peptides.

[19]  E. Richelson,et al.  Bioactive analogs of neurotensin: Focus on CNS effects , 2006, Peptides.

[20]  J. Vincent,et al.  Functional roles of the NTS2 and NTS3 receptors , 2006, Peptides.

[21]  F. St-Gelais,et al.  The role of neurotensin in central nervous system pathophysiology: what is the evidence? , 2006, Journal of psychiatry & neuroscience : JPN.

[22]  C. Nemeroff,et al.  Novel treatments of schizophrenia: targeting the neurotensin system. , 2006, CNS & neurological disorders drug targets.

[23]  A. Deutch,et al.  Neurotensin Activates GABAergic Interneurons in the Prefrontal Cortex , 2005, The Journal of Neuroscience.

[24]  K. Fuxe,et al.  Neurotensin enhances endogenous extracellular glutamate levels in primary cultures of rat cortical neurons: involvement of neurotensin receptor in NMDA induced excitotoxicity. , 2004, Cerebral cortex.

[25]  P. Rompré,et al.  Role of Calcium in Neurotensin-Evoked Enhancement in Firing in Mesencephalic Dopamine Neurons , 2004, The Journal of Neuroscience.

[26]  F. Lee,et al.  Regulation of Dopamine D1 Receptor Function by Physical Interaction with the Nmda Receptors Functional Interactions between Dopamine D1-like Receptors and Nmda Subtype Glutamate Receptors Have Been Implicated in the Maintenance of Normal Brain Activity and Neurological Dysfunction. Although Modulati , 2022 .

[27]  A. Belmeguenai,et al.  Neurotensin stimulates both calcium mobilization from inositol trisphosphate-sensitive intracellular stores and calcium influx through membrane channels in frog pituitary melanotrophs. , 2003, Endocrinology.

[28]  D. Lorrain,et al.  Effects of ketamine and n-methyl-d-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268 , 2003, Neuroscience.

[29]  K. Fuxe,et al.  Neurotensin enhances glutamate excitotoxicity in mesencephalic neurons in primary culture , 2002, Journal of neuroscience research.

[30]  Yu Tian Wang,et al.  Dual Regulation of NMDA Receptor Functions by Direct Protein-Protein Interactions with the Dopamine D1 Receptor , 2002, Cell.

[31]  K. Fuxe,et al.  Neurotensin-induced modulation of dopamine D2 receptors and their function in rat striatum: Counteraction by a NTR1-like receptor antagonist , 2002, Neuroreport.

[32]  F. Mora,et al.  NMDA and AMPA/kainate glutamatergic agonists increase the extracellular concentrations of GABA in the prefrontal cortex of the freely moving rat: modulation by endogenous dopamine , 2002, Brain Research Bulletin.

[33]  E. Richelson,et al.  Neurotensin analogs indications for use as potential antipsychotic compounds. , 2002, Life Science.

[34]  C. Nemeroff,et al.  Neurotensin and dopamine interactions. , 2001, Pharmacological reviews.

[35]  J. Reubi,et al.  Localization and characterization of neuropeptide receptors in human colon , 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.

[36]  M. Bennett,et al.  Protein kinase C modulates NMDA receptor trafficking and gating , 2001, Nature Neuroscience.

[37]  C. Nemeroff,et al.  The effects of glutamate receptor agonists on neurotensin release using in vivo microdialysis. , 2001, European journal of pharmacology.

[38]  K. Fuxe,et al.  Nigral neurotensin receptor regulation of nigral glutamate and nigroventral thalamic GABA transmission: a dual-probe microdialysis study in intact conscious rat brain , 2001, Neuroscience.

[39]  K. Fuxe,et al.  Neurotensin increases endogenous glutamate release in rat cortical slices. , 2000, Life sciences.

[40]  J P Vincent,et al.  Neurotensin and neurotensin receptors. , 1999, Trends in pharmacological sciences.

[41]  P. Soubrié,et al.  Stimulation by neurotensin of (3H)5-hydroxytryptamine (5HT) release from rat frontal cortex slices , 1998, Neuropeptides.

[42]  K. Fuxe,et al.  The Striatal Neurotensin Receptor Modulates Striatal and Pallidal Glutamate and GABA Release: Functional Evidence for a Pallidal Glutamate–GABA Interaction via the Pallidal–Subthalamic Nucleus Loop , 1998, The Journal of Neuroscience.

[43]  K. Fuxe,et al.  Differential Effects of lntrastriatal Neurotensin(1–13) and Neurotensin(8–13) on Striatal Dopamine and Pallidal GABA Release. A Dual‐probe Microdialysis Study in the Awake Rat , 1997, The European journal of neuroscience.

[44]  Bita Moghaddam,et al.  Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex , 1997, The Journal of Neuroscience.

[45]  P Ferrara,et al.  Molecular cloning of a levocabastine‐sensitive neurotensin binding site , 1996, FEBS letters.

[46]  T. Svensson,et al.  Effects of d-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat , 1995, Behavioural Brain Research.

[47]  G. Allen,et al.  Neurochemical changes following occlusion of the middle cerebral artery in rats , 1995, Neuroscience.

[48]  U. Ungerstedt,et al.  Neurotensin increases endogenous glutamate release in the neostriatum of the awake rat. , 1995, Synapse.

[49]  G. Hanson,et al.  The role of NMDA receptor systems in neuropeptide responses to stimulants of abuse. , 1995, Drug and alcohol dependence.

[50]  K. Fuxe,et al.  Strong effects of NT/NN peptides on DA D2 receptors in rat neostriatal sections. , 1994, Neuroreport.

[51]  K. Fuxe,et al.  Facilitation of gaba release by neurotensin is associated with a reduction of dopamine release in rat nucleus accumbens , 1994, Neuroscience.

[52]  F. Mora,et al.  Effects of neurotensin on the release of glutamic acid in the prefrontal cortex and striatum of the rat. , 1993, Neuroreport.

[53]  R. Roth,et al.  Dopamine‐Neurotensin Interactions in Mesocortical Neurons , 1992 .

[54]  A. Deutch,et al.  The Current Status of Neurotensin‐Dopamine Interactions , 1992 .

[55]  U. Ungerstedt,et al.  Evidence for a substrate of neuronal plasticity based on pre- and postsynaptic neurotensin-dopamine receptor interactions in the neostriatum. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[56]  R. Roth,et al.  Effects of CNS stimulants on the in vivo release of the colocalized transmitters, dopamine and neurotensin, from rat prefrontal cortex , 1992, Neuroscience Letters.

[57]  G. Hanson,et al.  Role of N-methyl-d-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems , 1992, Brain Research.

[58]  M. Mayer,et al.  Excitatory amino acid receptors, second messengers and regulation of intracellular Ca2+ in mammalian neurons. , 1990, Trends in pharmacological sciences.

[59]  L. Cubeddu,et al.  Neurotensin-induced dopamine release in vivo and in vitro from substantia nigra and nucleus caudate. , 1990, The Journal of pharmacology and experimental therapeutics.

[60]  U. Ungerstedt,et al.  Neurotensin counteracts apomorphine-induced inhibition of dopamine release as studied by microdialysis in rat neostriatum , 1989, Brain Research.

[61]  K. Fuxe,et al.  Neurotensin modulates the binding characteristics of dopamine D2 receptors in rat striatal membranes also following treatment with toluene. , 1989, Acta physiologica Scandinavica.

[62]  R. Quirion,et al.  Comparative localization of neurotensin receptors on nigrostriatal and mesolimbic dopaminergic terminals , 1985, Brain Research.

[63]  L. Swanson.  The Rat Brain in Stereotaxic Coordinates, George Paxinos, Charles Watson (Eds.). Academic Press, San Diego, CA (1982), vii + 153, $35.00, ISBN: 0 125 47620 5 , 1984 .

[64]  K. Fuxe,et al.  Neurotensin in vitro markedly reduces the affinity in subcortical limbic 3H-N-propylnorapomorphine binding sites. , 1983, Acta physiologica Scandinavica.

[65]  T. Hökfelt,et al.  On the functional role of coexistence of 5-HT and substance P in bulbospinal 5-HT neurons. Substance P reduces affinity and increases density of 3H-5-HT binding sites. , 1983, Acta physiologica Scandinavica.

[66]  R. Carraway,et al.  Isolation of a tridecapeptide from bovine intestinal tissue and its partial characterization as neurotensin. , 1976, The Journal of biological chemistry.

[67]  R. Carraway,et al.  The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. , 1973, The Journal of biological chemistry.

[68]  C. Nemeroff,et al.  Involvement of neuropeptide systems in schizophrenia: human studies. , 2007, International review of neurobiology.

[69]  U. Ungerstedt,et al.  Neurotensin peptides antagonistically regulate postsynaptic dopamine D2 receptors in rat nucleus accumbens: a receptor binding and microdialysis study , 2005, Journal of Neural Transmission / General Section JNT.

[70]  P. Soubrié,et al.  Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[71]  R. Roth,et al.  Dopamine-neurotensin interactions in mesocortical neurons. Evidence from microdialysis studies. , 1992, Annals of the New York Academy of Sciences.

[72]  A. Deutch,et al.  The current status of neurotensin-dopamine interactions. Issues and speculations. , 1992, Annals of the New York Academy of Sciences.

[73]  C. Nemeroff,et al.  Neurotensin-dopamine interactions in the CNS , 1985 .

[74]  C. Nemeroff.  Neurotensin: perchance an endogenous neuroleptic? , 1980, Biological psychiatry.